Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The molecular oncology of bilateral high-grade thalamic astrocytomas in children.

Goodarzi A, Garza N, Lechpammer M, Anthony R, Zwienenberg M.

Childs Nerv Syst. 2019 Nov;35(11):2047-2054. doi: 10.1007/s00381-019-04372-0. Epub 2019 Sep 14.

PMID:
31522255
2.

Pediatric thalamic tumors in the MRI era: a Canadian perspective.

Steinbok P, Gopalakrishnan CV, Hengel AR, Vitali AM, Poskitt K, Hawkins C, Drake J, Lamberti-Pasculli M, Ajani O, Hader W, Mehta V, McNeely PD, McDonald PJ, Ranger A, Vassilyadi M, Atkinson J, Ryall S, Eisenstat DD, Hukin J.

Childs Nerv Syst. 2016 Feb;32(2):269-80. doi: 10.1007/s00381-015-2968-z. Epub 2015 Nov 23.

PMID:
26597682
3.

Pediatric Thalamic Gliomas: An Updated Review.

Gupta A, Shaller N, McFadden KA.

Arch Pathol Lab Med. 2017 Oct;141(10):1316-1323. doi: 10.5858/arpa.2017-0249-RA. Review.

PMID:
28968159
4.

Bilateral thalamic tumors in children.

Di Rocco C, Iannelli A.

Childs Nerv Syst. 2002 Aug;18(8):440-4. Epub 2002 Jul 2.

PMID:
12192503
5.

Bilateral Thalamic Glioma: Case Report and Review of the Literature.

Balasa A, Balasa R, Egyed-Zsigmond I, Chinezu R.

Turk Neurosurg. 2016;26(2):321-4. doi: 10.5137/1019-5149.JTN.10884-14.2. Review.

6.

Diagnostic difficulties in childhood bilateral thalamic astrocytomas.

Gudowius S, Engelbrecht V, Messing-Jünger M, Reifenberger G, Gärtner J.

Neuropediatrics. 2002 Dec;33(6):331-5.

PMID:
12571791
7.

Thalamic tumors in children: a reappraisal.

Puget S, Crimmins DW, Garnett MR, Grill J, Oliveira R, Boddaert N, Wray A, Lelouch-Tubiana A, Roujeau T, Di Rocco F, Zerah M, Sainte-Rose C.

J Neurosurg. 2007 May;106(5 Suppl):354-62.

PMID:
17566201
8.

Surgical Management and Outcome of a Bilateral Thalamic Pilocytic Astrocytoma: Case Report and Review of the Literature.

Konar SK, Shukla D, Nandeesh BN, Prabhuraj AR, Devi BI.

Pediatr Neurosurg. 2019;54(2):139-142. doi: 10.1159/000495990. Epub 2019 Jan 24. Review.

PMID:
30677772
9.

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.

Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M.

Strahlenther Onkol. 2003 Sep;179(9):585-97. Review.

PMID:
14628124
10.

H3 K27M Mutations in Thalamic Pilocytic Astrocytomas with Anaplasia.

El Ahmadieh TY, Plitt A, Kafka B, Aoun SG, Raisanen JM, Orr B, Pan E, Wardak Z, Nedzi LA, Patel TR.

World Neurosurg. 2019 Jan 10. pii: S1878-8750(19)30015-4. doi: 10.1016/j.wneu.2018.12.147. [Epub ahead of print]

PMID:
30639498
11.

Role of Intraoperative Neurophysiologic Monitoring in the Resection of Thalamic Astrocytomas.

Carrabba G, Bertani G, Cogiamanian F, Ardolino G, Zarino B, Di Cristofori A, Locatelli M, Caroli M, Rampini P.

World Neurosurg. 2016 Oct;94:50-56. doi: 10.1016/j.wneu.2016.06.049. Epub 2016 Jun 23.

PMID:
27338215
12.

Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.

Wood MD, Halfpenny AM, Moore SR.

Diagn Pathol. 2019 Apr 9;14(1):29. doi: 10.1186/s13000-019-0802-8. Review.

13.

Bithalamic involvement predicts poor outcome among children with thalamic glial tumors.

Reardon DA, Gajjar A, Sanford RA, Heideman RL, Walter AW, Thompson SJ, Merchant TE, Li H, Jenkins JJ, Langston J, Boyett JM, Kun LE.

Pediatr Neurosurg. 1998 Jul;29(1):29-35.

PMID:
9867348
14.

ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.

Tomaselli S, Galeano F, Massimi L, Di Rocco C, Lauriola L, Mastronuzzi A, Locatelli F, Gallo A.

BMC Cancer. 2013 May 22;13:255. doi: 10.1186/1471-2407-13-255.

15.

Thalamic gliomas in children: an extensive clinical, neuroradiological and pathological study of 14 cases.

Fernandez C, Maues de Paula A, Colin C, Quilichini B, Bouvier-Labit C, Girard N, Scavarda D, Lena G, Figarella-Branger D.

Childs Nerv Syst. 2006 Dec;22(12):1603-10. Epub 2006 Sep 2.

PMID:
16951965
16.

Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.

Buczkowicz P, Bartels U, Bouffet E, Becher O, Hawkins C.

Acta Neuropathol. 2014 Oct;128(4):573-81. doi: 10.1007/s00401-014-1319-6. Epub 2014 Jul 22.

17.

Surgical management of thalamic gliomas: case selection, technical considerations, and review of literature.

Sai Kiran NA, Thakar S, Dadlani R, Mohan D, Furtado SV, Ghosal N, Aryan S, Hegde AS.

Neurosurg Rev. 2013 Jul;36(3):383-93. doi: 10.1007/s10143-013-0452-3. Epub 2013 Jan 25.

PMID:
23354786
18.

High CHI3L1 expression is associated with glioma patient survival.

Steponaitis G, Skiriutė D, Kazlauskas A, Golubickaitė I, Stakaitis R, Tamašauskas A, Vaitkienė P.

Diagn Pathol. 2016 Apr 27;11:42. doi: 10.1186/s13000-016-0492-4.

19.

Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.

Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, Pfister S, von Deimling A, Hartmann C.

Acta Neuropathol. 2009 Sep;118(3):401-5. doi: 10.1007/s00401-009-0550-z. Epub 2009 Jun 19.

PMID:
19543740
20.

Nuclear factor IA is expressed in astrocytomas and is associated with improved survival.

Song HR, Gonzalez-Gomez I, Suh GS, Commins DL, Sposto R, Gilles FH, Deneen B, Erdreich-Epstein A.

Neuro Oncol. 2010 Feb;12(2):122-32. doi: 10.1093/neuonc/nop044. Epub 2010 Jan 25.

Supplemental Content

Support Center